| | | | | | | |

Phone Triage for Veterans with Suspected Malignant Mesothelioma

1213235_navyA plan to offer triage by telephone to veterans suspected of having malignant mesothelioma may enable them to access expert mesothelioma advice faster, potentially improving their long-term outcomes.

In a newly published article in the Journal of Surgical Research, surgeons with VA Boston Healthcare System detail their experience with telephone triage of suspected malignant mesothelioma patients and explain how the system could help veterans around the country with other rare diseases.

Veterans Prone to Mesothelioma

Although pleural mesothelioma is an extremely rare cancer affecting fewer than 3,000 people in the US each year, veterans are disproportionately impacted because so many of them were exposed to asbestos.

Navy veterans are among the most common victims of mesothelioma because of their work in close quarters on ships that were often filled with various types of asbestos insulation.

Electricians, plumbers, boilermakers, shipbuilders, auto brake mechanics, and others who may have been exposed to asbestos in the course of their work in the military or civilian life all face a higher lifetime risk for developing mesothelioma.

Telephone Triage for Mesothelioma Patients

To determine the effectiveness of telephone triage in managing mesothelioma, the Boston team assessed the outcomes of 60 veterans were were screened by the system.

Specifically, they wanted to determine how much time elapsed between a suspected mesothelioma patient’s first telephone assessment and their physical examination in the general thoracic clinic in Boston.

Just as importantly, the study aimed to determine whether those examinations resulted in an altered mesothelioma treatment plan (and the potential for improved mesothelioma outcomes) in any of these patients.  

Triage Results in Timely, Expert Mesothelioma Care

As a result of their telephone triage, 38 of the 60 suspected mesothelioma patients were recommended for evaluation at VA Boston Healthcare and traveled an average of nearly 1,000 miles to get there.

It took an average of two weeks from their initial phone contact until their physical exam but, once they were seen by mesothelioma specialists, 71 percent had their treatment plans altered. VA Boston Healthcare bases its treatment planning for mesothelioma on the 2012 International Mesothelioma Interest Group Guidelines.

“Our initial experience demonstrates that in-network centralized care for Veterans with malignant pleural mesothelioma is feasible within the VHA,” concludes lead author Charles Jeff Siegert, MD, a thoracic surgeon at VA Boston Healthcare. “National open access phone triage improves access to expert surgical advice and can be delivered in a timely manner for Veterans using our service.”

One of the biggest challenges for veterans or anyone else suspected of having pleural mesothelioma is that, depending upon where they live, their evaluating physician may have little or no experience recognizing or treating this rare cancer.

Mesothelioma research has consistently shown that patients evaluated and treated in larger cancer centers by specialists familiar with malignant mesothelioma tend to have better outcomes and longer survival.

Source:

Siegert, CJ, et al, “Open access phone triage for veterans with suspected malignant pleural mesothelioma”, January 2017, Journal of Surgical Research, pp. 108- 114

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…